We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
-4.5%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$508M
AUM Growth
+$83.8M
Cap. Flow
+$371M
Cap. Flow %
73%
Top 10 Hldgs %
48.66%
Holding
368
New
95
Increased
39
Reduced
35
Closed
113

Top Buys

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$25.5M
2
MSTR icon
Strategy Inc
MSTR
+$22.3M
3
IMCR icon
Immunocore
IMCR
+$13M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$11.2M
5
BABA icon
Alibaba
BABA
+$9.93M

Sector Composition

Rank Sector Weight
1 Technology 24.85%
2 Financials 17.41%
3 Communication Services 10.98%
4 Consumer Discretionary 8.69%
5 Healthcare 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAN
151
DELISTED
GAN Ltd
GAN
$148K 0.03%
100,000
PSTX
152
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$147K 0.03%
50,205
-25,000
-33% -$68.4K
TBPH icon
153
Theravance Biopharma
TBPH
$874M
$136K 0.03%
16,000
-2,000
-11% -$18.1K
ANL
154
Adlai Nortye
ANL
$805M
$131K 0.03%
40,310
CDZI icon
155
Cadiz
CDZI
$266M
$124K 0.02%
40,000
MTTR
156
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$117K 0.02%
+26,200
New +$99.3K
SQQQ icon
157
ProShares UltraPro Short QQQ
SQQQ
$2.21B
$116K 0.02%
+560
New +$143K
WESTW
158
DELISTED
Westrock Coffee Company Warrants
WESTW
$111K 0.02%
50,043
MESO
159
Mesoblast
MESO
$1.99B
$110K 0.02%
+16,195
New +$111K
URG
160
Ur-Energy
URG
$485M
$108K 0.02%
+77,124
New +$128K
ADVM
161
DELISTED
Adverum Biotechnologies
ADVM
$106K 0.02%
15,446
EU
162
enCore Energy
EU
$221M
$105K 0.02%
+26,656
New +$118K
XOM icon
163
CALL
ExxonMobil
XOM
$651B
$105K 0.02%
+739,500
New +$86.1M
PBM icon
164
Psyence Biomedical
PBM
$11.3M
$101K 0.02%
90
MSFT icon
165
CALL
Microsoft
MSFT
$2.84T
$101K 0.02%
+498,000
New +$210M
AILEW
166
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$94.6K 0.02%
140,200
EVE.WS
167
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$88.7K 0.02%
806,620
IOVA icon
168
PUT
Iovance Biotherapeutics
IOVA
$2.23B
$86.3K 0.02%
+50,000
New +$536K
FDMT icon
169
PUT
4D Molecular Therapeutics
FDMT
$526M
$85K 0.02%
+50,000
New +$1.25M
GBTG icon
170
American Express Global Business Travel
GBTG
$4.91B
$81.6K 0.02%
+12,361
New +$75.8K
SVRA icon
171
Savara
SVRA
$1.13B
$80.6K 0.02%
+20,000
New +$89K
AAGR
172
DELISTED
African Agriculture Holdings Inc
AAGR
$75.3K 0.01%
279,112
GRAB icon
173
Grab
GRAB
$13.5B
$74.7K 0.01%
+21,056
New +$73.9K
MSOS icon
174
AdvisorShares Pure US Cannabis ETF
MSOS
$864M
$73.3K 0.01%
10,000
HEPS
175
D-Market Electronic Services & Trading
HEPS
$1B
$71.2K 0.01%
32,200

Similar funds

Cantor Fitzgerald's Q2 2024 Portfolio in Review

As of Q2 2024, Cantor Fitzgerald held 368 positions worth $508M, up 20% from $424M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Cantor Fitzgerald deployed $371M of net new capital in Q2 2024, opening 95 new positions and adding to 39 existing holdings. Its largest new stake was Super Micro Computer: 298,270 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 14% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was ProShares UltraPro QQQ, an estimated $20.1M trimmed.

  • Cantor Fitzgerald's largest Q2 2024 buy was Super Micro Computer: 298,270 shares worth $24.4M.
  • Cantor Fitzgerald added most to Strategy Inc in Q2 2024, an estimated $22.3M increase.
  • Cantor Fitzgerald's biggest Q2 2024 reduction was ProShares UltraPro QQQ, cutting an estimated $20.1M.
  • Cantor Fitzgerald fully exited Inhibrx, Inc. Common Stock in Q2 2024, selling an estimated $4.88M.
  • Cantor Fitzgerald's ten largest holdings make up 49% of its $508M portfolio in Q2 2024.
  • Cantor Fitzgerald opened 95 new positions and closed 113 in Q2 2024.
  • Cantor Fitzgerald's portfolio value rose 20% quarter-over-quarter to $508M.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.